📰 Nasdaq Nlsp News
Nasdaq Nlsp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Nlsp. Real-time updates on events, politics, business and more.
January 1, 2024
NLS Pharmaceutics (NASDAQ:NLSP – Get Free Report) and GlycoMimetics (NASDAQ:GLYC – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Earnings and Valuation This table compares NLS Pharmaceutics and […]
May 31, 2023
NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) shares rose 1.9% during mid-day trading on Tuesday . The company traded as high as $1.11 and last traded at $1.07. Approximately 46,216 shares changed hands during trading, a decline of 27% from the average daily volume of 62,937 shares. The stock had previously closed at $1.05. NLS […]
May 11, 2023
NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating)’s share price was down 2.9% during trading on Monday . The company traded as low as $1.23 and last traded at $1.34. Approximately 103,750 shares changed hands during trading, an increase of 48% from the average daily volume of 70,204 shares. The stock had previously closed at $1.38. […]
April 19, 2023
NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totalling 126,700 shares, an increase of 44.3% from the March 15th total of 87,800 shares. Currently, 0.6% of the company’s stock are short sold. Based on an average […]
June 15, 2022
NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 134,500 shares, a growth of 40.8% from the May 15th total of 95,500 shares. Based on an average trading volume of 94,200 shares, the short-interest ratio is […]
May 10, 2022
NLS Pharmaceutics (NASDAQ:NLSP – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “NLS Pharmaceutics Ltd. is a clinical-stage pharmaceutical company. It is focused on the discovery and development of therapies for rare and complex […]
April 17, 2022
NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 159,600 shares, a growth of 39.3% from the March 15th total of 114,600 shares. Based on an average daily volume of 282,700 shares, the short-interest ratio is […]
April 13, 2022
Zacks Investment Research upgraded shares of NLS Pharmaceutics (NASDAQ:NLSP – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, “NLS Pharmaceutics Ltd. is a clinical-stage pharmaceutical company. It is focused on the discovery and development of therapies for rare and […]
March 13, 2022
NLS Pharmaceutics AG (NASDAQ:NLSP – Get Rating) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 143,100 shares, an increase of 246.5% from the February 13th total of 41,300 shares. Currently, 1.8% of the company’s stock are sold short. Based […]